ALAB Astera Labs, Inc. Common Stock Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
16:41
Jul 16
The author dismisses the quoted list of beaten-down momentum names as never attractive on valuation, but does not express a personal long or short position, only a skeptical watchlist view.
ALAB
08:43
Jul 10
Ozark Bull market enjoyer, crypto trader
Reports that fund manager Gavin Baker bought $ALAB, betting on higher token spending with low-cost model composition. Speaker expresses surprise but no personal directional view.
ALAB
MED
14:01
Jul 08
ParadisLabs AI/Semiconductor Analyst
Long ALAB as a confirmed held position in author's high-concentration AI/semi portfolio; part of the inverse rotation basket that rallies when software names sell off.
ALAB
MED
00:49
Jul 08
TheValueist Founder, Atlas Peak Research
Watch ALAB as beneficiary of CXL adoption for inference workloads; Penguin’s CXL traction validates memory fabric thesis.
ALAB
MED
22:52
Jul 07
Buy ALAB as an optical I/O chiplet beneficiary of the CPO ramp; author's thesis is that the physics-driven migration to CPO at hyperscale GPU cluster densities creates structural demand for optical I/O chiplet suppliers independent of individual vendor qualification outcomes.
ALAB 1ST
MED
17:01
Jul 07
ParadisLabs AI/Semiconductor Analyst
Long ALAB as a high-conviction AI/semi name. Author holds through -14.1% weekly drop and explicitly states intent to keep the position.
ALAB
MED
19:19
Jul 06
TheValueist Founder, Atlas Peak Research
Monitor these Analog Century names; the author is long many of them but does not specify per-ticker ownership, so default to watch.
ALAB
MED
10:29
Jul 05
Author discloses Astera Labs as a current basket holding in the connectivity layer of an AI infrastructure portfolio; mentioned alongside Credo as a connectivity play.
ALAB
MED
21:03
Jul 01
ParadisLabs AI/Semiconductor Analyst
Long ALAB as an explicitly owned high-conviction AI name; author holding through -10.8% drawdown with no intent to sell.
ALAB 1ST
MED
16:55
Jul 01
temple_eight AI Photonics Trader
Author names Astera Labs as a potential beneficiary of a rumored memory-efficiency AI architecture breakthrough from an OpenAI spinout, per quoted context.
ALAB
MED
00:51
Jul 01
Astera Labs benefits from its Microsoft partnership.
Astera Labs is expected to experience a quantum jump based on its partnership with Microsoft for CXL technology. Its order backlog is growing rapidly, making it a strong alternative or complement to Marvell.
ALAB 1ST
MED
20:08
Jun 30
Reports past performance of ALAB within the author's "Best Ideas 2026" basket — no forward thesis or catalyst stated.
ALAB
LOW
20:29
Jun 28
Intel CEO Lip-Bu Tan cited investing in Astera Labs alongside Credo as interconnect bottleneck plays; author frames both as smart-money destinations per a named CEO's disclosed investment thesis.
ALAB
MED
19:46
Jun 27
Author views ALAB as a quality business but considers current valuation unattractive, declining to add exposure at present prices.
ALAB
MED
17:51
Jun 27
The author reflects on grading ALAB with a bias from past gains but does not state a current position or forward call.
ALAB
LOW
17:46
Jun 27
Buy ALAB on structural economic capture: non-GAAP gross margins of 76.4%, content per accelerator rising from ~$75 at IPO to $1,000+ today with 20-25% ASP step-ups per retimer generation, and COSMOS software deeply embedded in hyperscaler fleet operations creating durable switching costs; key risks are fabless supply dependency and heavy customer concentration, with the 2027-2028 Scorpio/UALink/optical roadmap still priced in but unproven.
ALAB
HIGH
14:53
Jun 27
Speaker notes ALAB is high quality but too expensive to add at current price, no directional commitment.
ALAB
LOW
21:43
Jun 24
bryzonx AI Photonics Trader
Author names ALAB as a bullish candidate in response to a direct question about which companies to look at, expressing conviction all named names will outperform.
ALAB 1ST
MED
19:40
Jun 23
TheValueist Founder, Atlas Peak Research
Watch ALAB as a high-growth AI connectivity play; the author provides deep research but no personal position, default to watch.
ALAB
MED
19:16
Jun 23
TheValueist Founder, Atlas Peak Research
Watch Astera Labs as a high-quality AI connectivity company; the research note is analytical, not a personal position, and valuation is extreme.
ALAB
MED
14:34
Jun 23
ParadisLabs AI/Semiconductor Analyst
Long ALAB as a quality supply-chain name added during the memory dip.
ALAB
MED
06:08
Jun 23
Author shares a comp table and research on connectivity stocks but does not state a position or forward-looking call, only providing factual analysis for investors to draw their own conclusions.
ALAB
LOW
02:27
Jun 23
aleabitoreddit Reddit DD Author / Independent Trader
Author notes past gains in ALAB and MRVL from CXL memory pooling but frames the best entry as historical, not a current position.
ALAB
LOW
21:58
Jun 22
bubbleboi Foundry Equipment Trader
Buy Astera Labs as the only credible full-stack CXL play — switches, cards, cables, and high-margin orchestration software create a sticky one-stop solution; $308M revenue +93% YoY into a $20B scale-up switch TAM by 2030, with software eventually approaching 100% margins.
ALAB
HIGH
10:52
Jun 22
ALAB joins the Nasdaq-100 effective this morning; passive ETF forced buying creates mechanical demand catalyst at open.
ALAB
MED
19:28
Jun 21
Buy ALAB ahead of Nasdaq 100 inclusion; mechanical passive rebalancing forces price-insensitive buying from 200+ index products, with ALAB's AI connectivity silicon positioning adding fundamental growth narrative alongside the technical flow catalyst.
ALAB 1ST
MED
18:17
Jun 21
Buy ALAB as author names it best-in-class in networking alongside CRDO, responding to a direct question about which names are best positioned in the sector.
ALAB
MED
01:30
Jun 21
Co-mentioned in connectivity sector fragmentation analysis as outperforming; included in comparative valuation article examining product mix, growth, and multiples.
ALAB
MED
17:12
Jun 19
Co-mentioned in comparative thesis as an example of a focused, one-sentence customer pain company in AI infrastructure — easier to underwrite than a full-stack story.
ALAB
MED
11:50
Jun 19
Author discloses an ongoing long position in ALAB with explicit long-term conviction, retaining a healthy stake even after a partial trim following strong gains.
ALAB
MED

About ALAB Analyst Coverage

Buzzberg tracks ALAB (Astera Labs, Inc. Common Stock) across 40 sources. 74 bullish vs 5 bearish calls from 39 analysts. Sentiment: predominantly bullish (43%). 160 total trade ideas tracked. Past 7 days: 1 watch. Latest voices: thematictrader, Ozark, ParadisLabs.